able instances of complications, whereas the HACs represent an undesirable condition arising during a hospital stay. It is worth noting that some of these indicators do not specifically measure a patient's outcome or the standard of care provided. Rather, they measure an aspect of care that is correlated with measures of quality or patient outcomes.
Because performance outcomes continue to be important factors for patients and hospitals as well as health care providers, newly proposed metrics such as PSIs and HACs need to be evaluated in specific clinical domains. Numerous outcomes have been considered to evaluate hospital performance. Some of these metrics include in-hospital mortality, 30-day readmissions, in-hospital length of stay, and complications, to name a few. 5, 8, 18, 19, 21, 25, 32, 35, 37 These outcomes have been evaluated in association with hospital procedural volume. An established association suggests that patients treated at higher-volume hospitals have a tendency to attain outcomes that are superior to those reported for patients treated at these hospitals' lower-volume counterparts. In this study, we evaluate the occurrence of safety-related adverse events (i.e., PSIs) and HACs for patients with brain tumor who underwent a craniotomy. Our study aims first to evaluate the association between PSIs, HACs, and in-hospital mortality rates, and second to assess any association between hospital volume, PSIs, and HACs. We anticipate that a confirmed association between PSIs, HACs, and mortality rates may motivate efforts to prevent or reduce the occurrence of these events, with the focus on improving in-hospital mortality. Similarly, establishing a correlation between hospital volume, PSIs, and HACs may support the use of these metrics as hospital performance measures in this patient population.
methods data source and cohort selection
We used the Nationwide Inpatient Sample (NIS) database to capture patients with brain tumor who had been surgically treated in US hospitals between 1998 and 2009. Data were obtained from the Healthcare Cost and Utilization Project of the AHRQ. 2 The NIS collects data for a stratified random sampling (20%) of hospitals that are representative of the American medical community. Using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, we identified adult patients (18 years of age or older) with a primary diagnosis of acoustic neuroma (ICD-9-CM: 225.1), meningioma (ICD-9-CM: 225.2), and malignant tumor (ICD-9-CM: 191. 0-191.9, 192.0, 192.1, 194.3, 194.4, 198. 3) of the brain; only patients who underwent either a biopsy (ICD-9-CM: 1.11-1.15, 1.18, 1.19) or a craniotomy (ICD-9-CM: 1.23-1.25, 1.31, 1.32, 1.39, 1.51-1.53, 1.59, 1.60) were included (Table 1) . The primary diagnosis code is the principal condition requiring admission for treatment, as determined by the admitting physician. 11 and hospital characteristics such as teaching status, hospital bed size, and hospital surgical volume were documented. Hospitals were classified into 1 of 4 cohorts (V1-V4) according to yearly surgical volume. The lowest-volume hospitals were designated by V1, whereas the highest-volume ones were referred to as V4 hospitals. The average number of procedures per year conducted in V1 hospitals ranged from 0 to 15, it was 16-50 among V2 hospitals, 51-100 for V3 hospitals, and 101 or more for hospitals designated by V4. Categorization of hospital cohorts according to procedural volume was reached based on volume thresholds that were deemed clinically relevant by neurosurgeons in our team (C.G.P., D.M.). It is worth noting that hospital volume was first evaluated as a continuous variable, and the findings were consistent with our results obtained using multiple categories. Data were missing for sex in 1410 (0.32%) patients, for race in 109,699 (24.7%), for income in 11,477 (2.6%), and for hospital teaching status and bed size in 1198 (0.30%).
outcomes of interest
Complications, as captured by PSIs, HACs, and inhospital mortality, were the main outcomes of interest in this study. Hospital procedural volume was a secondary outcome. The PSIs evaluated included the following: 1) decubitus ulcer; 2) iatrogenic pneumothorax; 3) central venous catheter-related bloodstream infections; 4) postoperative hip fracture; 5) postoperative hemorrhage or hematoma; 6) postoperative physiological and metabolic derangement; 7) postoperative respiratory failure; 8) postoperative PE or DVT; 9) postoperative sepsis; 10) postoperative wound dehiscence; and 11) accidental puncture or laceration during a procedure or medical care (Table 2) . A variable describing the number of days from admission to secondary procedures was used to confirm that all PSIs resulting from postsurgical procedures occurred within the index hospitalization of interest. The HACs considered were as follows: 1) foreign object retained after surgery; 2) air embolism; 3) falls and trauma; 4) catheter-associated UTI; 5) vascular catheter-associated infection; 6) manifestations of poor glycemic control; 7) diabetic ketoacidosis; 8) nonketotic hyperosmolar coma; 9) hypoglycemic coma; 10) secondary diabetes with ketoacidosis; and 11) secondary diabetes with hyperosmolarity.
statistical analysis
Descriptive statistics were used to summarize patient and hospital characteristics. A multivariate logistic regression model that adjusted for patient and hospital factors evaluated associations with PSI, HAC, and postprocedural mortality outcomes. Separate models were used to evaluate each of these outcomes (mortality, HAC, PSI). Adjustments were made for a patient's race and income, and these factors were found to have no additional predictive value or association in these predictive models. Chi-square and Student t-tests were used to evaluate differences in mortality rates for PSI versus non-PSI and HAC versus non-HAC cohorts as a function of hospital volume. Adjusted odds ratio (aOR), 95% CI, interquartile range (IQR), and corresponding p values were reported. Nationwide estimates were derived using the SAS PROC SURVEY methodology. All analysis used SAS version 9.1 for Windows (SAS Institute, Inc.).
results demographic data
According to the NIS database, 444,751 patients underwent brain tumor surgery at 1311 US hospitals between 1998 and 2009. The median patient age was 57 years (IQR 46-68 years) with a female preponderance (52.6%), and a significant portion (47.3%) of patients who had 2 or more preexisting conditions (Table 3) . Most patients were treated at teaching hospitals (76.3%). A significant fraction of patients underwent a craniotomy (87.2%) compared with biopsy (12.8%). Among the 1311 hospitals, 760 fell within the V1 cohort (lowest volume), 409 were in the V2 cohort, 86 in the V3 cohort, and the remaining 56 hospitals were placed among the highest-volume cohort (V4). In a univariate setting, the highest-volume hospitals compared with the lowest-volume ones had younger patients (54 vs 61 years, p < 0.0001), fewer females (51.7% vs 53.0%, p = 0.03), fewer comorbidities (40.9% vs 55.0%, p < 0.0001), and higher rates of craniotomy (89.4% vs 85.8%, p < 0.0001).
associations among psis, hacs, and mortality rates
Although the overall mortality rate was 1.9%, this rate increased to 11.8% (5.2-fold) with the occurrence of a PSI, and to 4.3% (1.3-fold) with an HAC. The strong association between a PSI and mortality was independent of hospital volume. Univariate analysis showed that the mortality rate of patients who experienced a PSI was 15.3% if treated at the lowest-volume (V1) hospitals compared with the 8.8% rate captured among highest-volume (V4) facilities (p < 0.0001, Fig. 1 ). While HACs were consistently associated with higher mortality rates, this finding was particularly significant (p = 0.003) if patients received treatment at V1 hospitals (Fig. 2) .
In a multivariate model that adjusted for a patient's age, sex, preexisting comorbidities, and hospital volume, among other factors, we found that the occurrence of a PSI was strongly associated with death (Table 4) . Patients who experienced a PSI were 7.6 times more likely to die during their hospitalization (aOR 7.6, CI 6.7-8.7). The occurrence of an HAC did not impact the odds of death in this cohort (aOR 1.0, CI 0.6-1.9).
Other factors shown to be marginally associated with increased odds of death included a patient's age (aOR 1.2, CI 1.1-1.2), more preexisting comorbidities (aOR 1.2, CI 1.1-1.2), and longer hospital stays (aOR 1.1, CI 1.1-1.1). Female sex was mildly associated with a reduction in the odds of death (aOR 0.9, CI 1.0-1.6).
associations among psis, hacs, and hospital volume
We found that 7.4% of patients contracted a PSI, and 0.4% experienced an HAC (Table 5 ). The most common adverse events in our cohort were postoperative PE or DVT (2.3%), postoperative respiratory failure (1.8%), and postoperative hemorrhage or hematoma (1.5%), statistics that are mirrored in previous studies focusing on alternate patient cohorts. 17, 34 In the univariate analysis, the lowest-volume hospitals had significantly higher rates of PSIs (8.7% vs 7.2%, p = 0.01) and HACs (0.7% vs 0.3%, p < 0.0001) than the highest-volume hospitals. The overall mortality rate was 1.9%, with a decreasing trend that persisted as hospital volume increased (p < 0.0001).
After adjusting for patient and hospital confounders, we found that hospital volume was marginally associated with the occurrence of a PSI (Table 6) . Patients who were treated at the highest-volume hospitals (V4) compared with the lowest-volume ones (V1) had a 10% reduction in the odds of a PSI (aOR 0.9, CI 0.8-1.0). A stronger association between hospital volume and HAC was documented (Table 7) . Patients treated at the highest-volume hospitals compared with the lowest-volume ones had a 50% reduction in the odds of experiencing an HAC (aOR 0.5, CI 0.3-0.8). The decreasing odds of an HAC were consistently observed among patients treated at V2 (aOR 0.7, CI 0.5-0.9) and V3 (aOR 0.6, CI 0.4-0.9) hospitals. 
discussion
Patients with brain tumors undergoing a craniotomy were found to experience a safety-related adverse event (i.e., PSI) at a rate of 7.4%. Significantly fewer patients (0.4%) contracted a HAC. Postoperative PE or DVT, followed by respiratory failure and hemorrhage/hematoma accounted for the majority of the adverse events. The PSI rates documented in our cohort were significantly lower than previously reported for patients with ruptured 16 and unruptured 17 brain aneurysms. In these studies, Fargen et al. aimed to establish PSIs and HACs as standard performance measures in patients with ruptured and unruptured aneurysms. They showed that the occurrence of a PSI or HAC was associated with longer hospital stays, higher charges, and greater in-hospital mortality rates in both ruptured and unruptured aneurysm cohorts. The occur- rence of a PSI was strongly associated with in-hospital mortality. Similar to these previous studies, we found that patients who experienced a PSI were 7.6 times more likely to die during their hospitalization that those who did not. This effect of a PSI on mortality is comparable to the 7-to 8-fold increase reported in patients with ruptured subarachnoid hemorrhage. 16 Additionally, our multivariate model demonstrated a significant protective effect of malignant lesions against the development of a PSI. Although this initially appears counterintuitive, given the limitations of a national database as well as the treatment and surgical factors involving these benign histological types (meningioma and vestibular schwannoma), this result is logically explicable. Meningiomas are often large tumors by the time patients undergo surgical intervention, thereby necessitating longer operating times and predisposing patients to postoperative events such as venous thromboembolisms and infectious complications. 28 In accordance with these considerations, 2 recent studies have reported a higher incidence of postoperative complications (namely hematoma and surgical site infection) in patients with meningioma as opposed to other intrinsic tumors, such as gliomas. 25, 33 Furthermore, postoperative meningitis is a well-known complication following skull base surgery, such as that for treatment of vestibular schwannoma.
6,12 In a study by Darrouzet et al., tumor size was a significant predictor of the development of meningitis postoperatively.
12 Furthermore, although tumor size and location are important confounding factors, we did not have access to these variables, and thus were unable to adjust for them in our multivariate model to evaluate these hypotheses.
In our bivariate evaluation of the correlation between PSIs, HACs, and hospital procedural volume, we found a strong association between HACs and volume; PSIs had a moderate correlation with hospital volume. Patients treated at the highest-volume hospitals were 50% less likely to experience an HAC compared with those treated at the lowest-volume facilities. Similarly, patients treated at the highest-volume hospitals experienced a 10% reduction in the odds of experiencing a safety-related adverse event.
Since the early work of Luft et al. demonstrating a relationship between operative volume and surgical outcomes, 27 numerous studies have explored similar correlations for several patient populations. Recent research supports an association between 30-day readmissions and procedural volume. tality had lower rates of surgical readmission than other hospitals. 37 Further studies have also reported a strong association between complications and volume.
7,22,32 With respect to PSIs and HACs, ours is one of the first studies to establish a correlation between these metrics and procedural volume for any patient population. In a smallersample-size study (2002-2009), Zacharia et al. showed higher rates of HACs in higher-volume centers. 38 We found that the highest-volume hospitals had fewer PSIs and HACs than the lowest-volume ones. Even after adjusting for factors such as a patient's age, preexisting conditions, and tumor type, among others, superior outcomes (lowest rates of mortality, PSIs, and HACs) among high-volume hospitals persisted. Differences in our results from Zacharia et al.'s study of HACs may be partially explained by the fact that they included DVT/PE as part of the HACs, whereas we did not. However, more important may be the fact that they dichotomized hospital volume into 2 categories (≤ 50 and > 50 cases per year), whereas we opted for more stratifications. Although it is difficult to discern the factors driving this volume-outcome trend, it is possible that greater awareness in protecting patients from postoperative complications, as previously noted, may in part provide a reasonable explanation for this relationship.
7,20 More experienced neurosurgeons, ancillary personnel, and advanced imaging technology available at high-volume hospitals may also account for the improved short-term outcomes.
Despite numerous efforts to provide equal access to health care, studies continue to highlight disparities in the management of this disease in adult and pediatric patients. 15, 26, 30, 31 In their 2010 study, Mukherjee et al. showed that Hispanic children in whom a brain tumor was diagnosed were less likely to receive high-quality treatment at specialized neurosurgery hospitals than other children with the same condition. 31 Epstein et al. also found that minority patients were substantially less likely to be treated at high-volume hospitals with reported lower mortality rates.
15 Disparities in access to specialized surgical care may additionally be part of the complex factors involved in this volume-outcome relationship. Future studies aimed at deciphering factors involved in outcome differences between high-and low-volume hospitals may consider factors such as differences in hospital referrals and in a patient's insurance and preferences.
In a technical review prepared by the UCSF-Stanford EPC for the AHRQ, it is reported that PSIs capture adverse events that may be related to medical care, but that also may be a result of other factors. 29 For example, the ability of PSIs to differentiate between preexisting conditions and those acquired during hospital admission remains open to debate.
5 As Bahl et al. reported, the rate of PSI occurrence in their cohort decreased on inclusion of a "present on admission" variable. This variable accounts for conditions that were present at admission, therefore minimizing false positives in reported PSI occurrence rates. Once patients' condition on admission was corrected for, the rates of a subset of PSIs were significantly reduced.
Although this study is limited by our inability to determine when a PSI occurred, a thorough inclusion of specific postsurgical PSIs and the confirmation that a procedure giving rise to a PSI occurred within the index hospital stay gives validity to the assertion that these condi- tions occurred during the hospitalization of interest rather than as preexisting conditions. As with any retrospective administrative database study, there are several strengths and inherent limitations. 3, 4, 14, 24, 36 In our study we adjusted for preexisting comorbidities by calculating the Elixhauser index score, yet we recognize that the reliability of this metric is strongly dependent on comprehensive documentation. Although we conjectured on several possibilities for the volume-outcome association, our study, similar to other national cohorts, was unable to identify the precise factors driving this interaction. A major strength of this study was our ability to assess PSIs and HACs across a wide variety of hospitals nationwide.
Quality indicators such as PSIs, HACs, and in-hospital mortality were developed with the goal of reflecting quality of care based on hospital administrative data that are collected as a standard effort of health care delivery (AHRQ). Our study showed that hospitals with a higher volume of craniotomies also had lower mortality, PSI, and HAC rates. However, caution must be exercised when generalizing this association of hospital performance to one of quality of care. High-volume, high-performance hospitals may not necessarily correspond to hospitals providing the highest quality of surgical care. The Institute of Medicine has defined quality of health care as "the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge."
23 Therefore, the definition of quality of care is two-sided, because it relies on both the demonstration of superior outcomes as well as adherence to current standards for quality of care. Because this study queried patients from the NIS, an administrative database, we did not have access to data regarding the quality of care. Therefore, due to this limitation, we are only able to comment on the performance of hospitals by volume in terms of these established metrics, rather than the quality of care provided.
conclusions
Patient safety-related adverse events were strongly associated with in-hospital mortality rates, whereas HACs were not. Moderate to strong correlations were found between PSI, HAC, and hospital procedural volume. Patients treated at the highest-volume hospitals had consistently lower rates of mortality, PSIs, and HACs compared with those treated at the lowest-volume facilities. In-hospital mortality, PSIs, and HACs all have been proposed as metrics of surgical quality. However, as per the dual definition of quality of care proposed by the Institute of Medicine, further work is required to establish a connection between performance metrics and the quality of surgical care in this patient population.
